See also this year's filing and all EDGAR filings for this company.
PDF Report 0001513525_2019_ADIAL_PHARMACEUTICALS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001513525')"} |
Graph
Absolute values for 0001513525, ADIAL PHARMACEUTICALS INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 4,692,550 |
1 | IntangibleAssetsNetIncludingGoodwill | 6,735 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 257,974 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 6,618,763 |
9 | ResearchAndDevelopmentExpense | 368,459 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -4,644,156 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 4,699,285 |
1 | Liabilities | 257,974 |
2 | Expenses | 6,987,222 |
3 | Revenues | 0 |
4 | StockholdersEquity | 4,441,311 |
5 | NetIncome | -11,631,378 |
6 | ComprehensiveNetIncome | -11,631,378 |
7 | BaseVar | 8,294,318 |
8 | EconomicCapitalRatio | -1.61 |